Campbell & Co. Investment Adviser »

Adma Biologics shares owned by Campbell & Co. Investment Adviser

Quarter-by-quarter ownership of Adma Biologics (ADMA) shares owned by Campbell & Co. Investment Adviser from 13F filings

Historical chart of Campbell & Co. Investment Adviser investment in Adma Biologics

Tip: Access up to 7 years of quarterly data

All positions including Adma Biologics held by Campbell & Co. Investment Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adma Biologics by Campbell & Co. Investment Adviser

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.2M 59k 19.99
2024-03-31 $1.5M 232k 6.60
2023-09-30 $431k 120k 3.58

More positions owned by Campbell & Co. Investment Adviser

Workday Common Stock (WDAY)
PepsiCo Common Stock (PEP)
Msci Common Stock (MSCI)
Amphenol Corp Common Stock (APH)
Everest Group Common Stock (EG)
Cognizant Technology Solutions Common Stock (CTSH)
Tenable Holdings Common Stock (TENB)
Marsh & McLennan Cos Common Stock (MMC)
Intercontinental Exchange Common Stock (ICE)
Allegion Common Stock (ALLE)
Maximus Common Stock (MMS)
Janus Henderson Group Common Stock (JHG)
Royal Bank of Canada Common Stock (RY)
Portland General Electric Common Stock (POR)
Equifax Common Stock (EFX)

View all positions for Campbell & Co. Investment Adviser

Top funds holding Adma Biologics

BlackRock
Vanguard Group
State Street Corporation
Invesco
Nuveen Asset Management
Geode Capital Management
D. E. Shaw & Co
Two Sigma Advisers
AWM Investment Company
American Century Companies
Deutsche Bank Aktiengesellschaft
Dimensional Fund Advisors
Renaissance Technologies
Perpetual
Two Sigma Investments

View all funds holding Adma Biologics